本页面由Tiger Trade Technology Pte. Ltd.提供服务

Organon & Co

6.85
+0.01000.15%
成交量:188.76万
成交额:1,292.41万
市值:17.81亿
市盈率:3.58
高:6.92
开:6.80
低:6.75
收:6.84
52周最高:17.23
52周最低:6.18
股本:2.60亿
流通股本:2.59亿
量比:0.54
换手率:0.73%
股息:0.34
股息率:4.96%
每股收益(TTM):1.91
每股收益(LYR):3.36
净资产收益率:71.62%
总资产收益率:6.40%
市净率:1.97
市盈率(LYR):2.04

数据加载中...

公司资料

公司名字:
Organon & Co
交易所:
NYSE
成立时间:
1923
员工人数:
10000
公司地址:
30 Hudson Street,Floor 33,Jersey City,New Jersey,United States
邮编:
07302
电话:
传真:
- -
简介:
Organon & Co.是一家特拉华州公司,成立于2020年3月11日。Organon是一家基于科学的全球制药公司,通过一系列针对女性健康,生物仿制药和知名品牌的处方疗法,开发并提供创新的健康解决方案。他们的使命是成为世界领先的女性保健公司,每天为每个女性提供更好,更健康的服务。他们计划利用自身在生殖健康方面的优势,建立一系列健康解决方案,为从青春期到更年期及以后的妇女提供服务。

董事

名称
职位
Alan Ezekowitz
Independent Director
Carrie S. Cox
Interim Executive Chair, Independent Director
Cynthia M. Patton
Independent Director
Deborah Leone
Independent Director
Grace Puma
Independent Director
Helene Gayle
Independent Director
Philip Ozuah
Independent Director
Robert Essner
Lead Independent Director
Rochelle B. Lazarus
Independent Director
Shalini Sharp
Independent Director

股东

名称
职位
Joseph Morrissey
Executive Vice President and Head of Manufacturing and Supply, Interim Chief Executive Officer
Matthew Walsh
Executive Vice President and Chief Financial Officer
Aaron Falcione
Executive Vice President and Chief Human Resources Officer
Daniel Karp
Executive Vice President, Corporate Development
Juan Camilo Arjona Ferreira
Executive Vice President, Head of Research & Development and Chief Medical Officer
Kirke Weaver
Executive Vice President, General Counsel and Corporate Secretary
Rachel Stahler
Executive Vice President and Chief Digital & Growth Officer
Vittorio Nisita
Executive Vice President and Head of Enterprise Services & Solutions